Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma. (Q53986670)

From Wikidata
Jump to navigation Jump to search
scientific article
  • Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposiʼs sarcoma
edit
Language Label Description Also known as
English
Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma.
scientific article
  • Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposiʼs sarcoma

Statements

Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma. (English)
Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposiʼs sarcoma (English)
0 references
0 references
Olivier Bouchaud
0 references
Agnès Goetschel
0 references
Geoffrey Mukwaya
0 references
Gerald Eestermans
0 references
Michael Ross
0 references
Willy Rozenbaum
0 references
Adrien Gérard Saimot
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit